|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
      |
|||||||||||||
 |
 |
|||||||||||||
   
 |
||||||||||||||
News
MiMedx Holds First Physician Advisory Board Meeting in San Diego
San Diego, Cal. — February 16, 2007 — MiMedx Inc. (MDX), an R&D company specializing in connective tissue technology, held its first Physician Advisory Board (PAB) meeting in San Diego today. Among those attending was Dr. Jimmy Andrews, Chairman of the Physician Advisory Board and leading orthopedic Surgeon.
Members of MiMedx’s PAB are physicians who consistently push medicine forward and develop new solutions to treat injury and diseases, and many of whom are chairman of their respective departments at university medical schools, teaching institutions and fellowship programs. A PAB is currently being assembled around the first intended uses, orthopedics sports medicine.
The Company is also forming a separate PAB for upper-extremity and plastic surgery indications. Thomas Graham, MD, Chairman of the National Hand Center located in Baltimore, MD, has agreed to chair this committee. Dr. Graham is the team physician for the Georgetown Hoyas, the Toronto Blue Jays, the Washington Nationals, and the Philadelphia Fliers. The National Hand Center is the largest practice specializing in hand surgery in the United States. Additionally, the Center has been designated by The United States Congress as the National Center for the Treatment of the Hand and Upper Extremity.
About Dr. Jimmy Andrews
Doctor James R. Andrews, orthopedic surgeon, is one of the founding members of the Alabama Sports Medicine and Orthopedic Center (ASMOC) and the American Sports Medicine Institute (ASMI) in Birmingham, Alabama, located at St. Vincent’s Hospital. He serves as Chairman and Medical Director of ASMI. Doctor Andrews is also a founding partner and Medical Director of the Andrews Institute located in Gulf Breeze, Florida.
Doctor Andrews is internationally known and recognized throughout the world for his scientific and clinic research contributions in knee, shoulder and elbow injuries, and his skill as an orthopedic surgeon.
About MiMedx, Inc.
Founded in 2006, MiMedx Inc. (MDX) is a development stage company whose technology focuses on biomaterials for soft tissue repair, such as tendons, ligaments and cartilage, as well as other biomaterial-based products for numerous other medical applications. The company, headquartered in Tampa, Florida, holds an exclusive, worldwide license from the Shriner’s Hospital for Children and the University of South Florida Research Foundation for its NDGA technology. MDX is targeting this proprietary technology for a myriad of diverse applications. Additional information is available at www.mimedx.com.
###
These statements have not been reviewed by the FDA.
This website is not meant as a substitute for professional medical advice.
|
|
 |
|
